Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 49.13B |
| Enterprise value | 48.60B |
| Trailing P/E | 32.60 |
| Forward P/E | 31.55 |
| PEG ratio (5-yr expected) | 3.93 |
| Price/sales (ttm) | 9.23 |
| Price/book (mrq) | 8.33 |
| Enterprise value/revenue | 9.03 |
| Enterprise value/EBITDA | 27.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.01 |
| 52-week change 3 | -33.72% |
| S&P500 52-week change 3 | -10.89% |
| 52-week high 3 | 131.10 |
| 52-week low 3 | 67.13 |
| 50-day moving average 3 | 78.87 |
| 200-day moving average 3 | 84.54 |
Share statistics
| Avg vol (3-month) 3 | 3.58M |
| Avg vol (10-day) 3 | 3.17M |
| Shares outstanding 5 | 606.1M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 602.8M |
| % held by insiders 1 | 0.84% |
| % held by institutions 1 | 87.32% |
| Shares short (14 Mar 2023) 4 | 16.94M |
| Short ratio (14 Mar 2023) 4 | 4.31 |
| Short % of float (14 Mar 2023) 4 | 2.81% |
| Short % of shares outstanding (14 Mar 2023) 4 | 2.78% |
| Shares short (prior month 14 Feb 2023) 4 | 11.96M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 31 May 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Dec 2022 |
Profitability
| Profit margin | 28.28% |
| Operating margin (ttm) | 33.29% |
Management effectiveness
| Return on assets (ttm) | 13.34% |
| Return on equity (ttm) | 26.14% |
Income statement
| Revenue (ttm) | 5.38B |
| Revenue per share (ttm) | 8.69 |
| Quarterly revenue growth (yoy) | 1.40% |
| Gross profit (ttm) | 4.3B |
| EBITDA | 1.93B |
| Net income avi to common (ttm) | 1.52B |
| Diluted EPS (ttm) | 2.44 |
| Quarterly earnings growth (yoy) | 18.80% |
Balance sheet
| Total cash (mrq) | 1.22B |
| Total cash per share (mrq) | 2 |
| Total debt (mrq) | 691.3M |
| Total debt/equity (mrq) | 11.90 |
| Current ratio (mrq) | 3.03 |
| Book value per share (mrq) | 9.55 |
Cash flow statement
| Operating cash flow (ttm) | 1.22B |
| Levered free cash flow (ttm) | 933.04M |
© 2023 Yahoo. All rights reserved.
